---
category: news
title: "BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced promising top-line data from its Phase 2 trial of BXCL701,"
publishedDateTime: 2023-01-11T13:43:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-promising-top-line-results-from-/2023/01/11/9741357.htm"
webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-promising-top-line-results-from-/2023/01/11/9741357.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "S5IrItwk0eVjvZ43v1CS2nXpPNQbjfEY9C2/gG5K08GtsyHG/oy8Hth7JwR94fGGb+XAFjB53IeLJUvJs+8ESrjVl2khQXkjizea4cDVeIEJwWOVzFcAN38KckFY/K8fjeEpasp51von9WfFr1T2D3D89txMx+d/BcX0HG5cQHWPoLukpEn5ahKGR8vlgBUfebwt2fQ8+Han0zIEUK1kAE3YieAv84aRkkXQZZaXIED980acqYPuyS4PtmB5AMUQRp4TjKbF5ero8eY9OSfzpvSiCH8ODwo88uUKg1oSXqnry+V/TuBzOsAjvQ1/BmoMjatvyg1BTTqD/YT17RQRL64Ah5QJNlWMhvOGSZKsdhY=;rJT8LwPUhledITT9YncTfw=="
---

